約翰斯疾病診斷市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

到 2023 年，全球約翰氏症診斷市場價值將達到 6.456 億美元，預計在預測期內複合年成長率為 5.2%。這種成長主要歸因於人們對約翰氏症及其對牲畜健康和生產力影響的認知不斷提高。約翰斯病是由鳥分枝桿菌副結核亞種 (MAP) 引起，是一種影響牛、綿羊和山羊的慢性胃腸道感染。隨著畜牧生產者越來越意識到這種疾病的經濟影響，對有效診斷解決方案的需求正在增加。

最近的統計數據強調了約翰氏症的廣泛流行及其對畜牧業的重大經濟影響，並強調了對先進診斷方法的需求。 PCR 和血清學檢測等診斷技術的進步顯著提高了檢測的準確性和速度。這些改進使診斷技術對獸醫和牲畜所有者更具吸引力。此外，對動物福利和永續農業實踐的重視進一步推動了採用可靠的診斷方法來有效識別和管理受感染的牲畜。

這些因素共同促進了約翰氏症診斷市場的正向成長軌跡。約翰斯病診斷採用多種方法來檢測 MAP，包括識別抗體的酶聯免疫吸附測定 (ELISA) 和檢測糞便樣本中的 MAP DNA 的聚合酶鏈反應 (PCR) 測試。早期準確的診斷對於控制疾病傳播和最大限度地減少經濟損失至關重要。按測試類型分類，PCR 細分市場在 2023 年佔據最大的市場佔有率，為 45.3%。

PCR 技術的創新也使其更容易用於獸醫診斷且更具成本效益，從而推動了其普及。人們越來越認知到約翰氏症對牲畜生產力的影響以及對可靠診斷工具的需求，進一步鞏固了 PCR 領域的地位。就動物類型而言，牛細分市場佔據主導地位，到2023 年價值將達到5.817 億美元。量、體重、和整體健康狀況。對早期檢測的需求支持了該領域診斷的成長。

從地區來看，北美引領約翰病診斷市場，2023 年價值為 2.718 億美元，預測期內複合年成長率預計為 5.1%。該地區先進的獸醫基礎設施、生產者意識的提高以及健全的疾病控制監管框架是關鍵的成長動力。同時，在政府強力的舉措以及 PCR 和 ELISA 等先進診斷技術的廣泛使用的支持下，2023 年美國市場規模為 2.487 億美元，預計到 2032 年將增至 3.809 億美元。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 牲畜數量增加
    • 獸醫醫療保健支出增加
    • 約翰氏症根除計畫和提高對副結核病的認知
  • 產業陷阱與挑戰
    • 測試的複雜性和耗時性
    • 疾病的無症狀性質
• 成長潛力分析
• 監管環境
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按測試類型，2021 - 2032 年

• 主要趨勢
• 酵素連結免疫吸附測定法 (ELISA)
• 聚合酶鍊式反應 (PCR)
• 瓊脂凝膠免疫擴散 (AGID)

第 6 章：市場估計與預測：按動物類型，2021 - 2032 年

• 主要趨勢
• 牛
• 山羊
• 羊
• 其他動物類型

第 7 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 8 章：公司簡介

• BioMerieux SA
• Idexx Laboratories, Inc.
• INDICAL BIOSCIENCE GmbH
• Innovative Diagnostics (IDvet)
• MV Diagnostics
• Pictor diagnostics
• Tetracore, Inc.
• Thermo Fisher Scientific Inc.
• VMRD, Inc.
• Zoetis Inc.

The Global Johnes Disease Diagnostics Market, valued at USD 645.6 million in 2023, is projected to expand at a CAGR of 5.2% over the forecast period. This growth is largely attributed to increasing awareness of Johnes disease and its impact on livestock health and productivity. Johnes disease, caused by Mycobacterium avium subspecies paratuberculosis (MAP), is a chronic gastrointestinal infection that affects cattle, sheep, and goats. As livestock producers become more aware of the financial repercussions of this disease, the demand for effective diagnostic solutions is rising.

Recent statistics highlight the widespread prevalence of Johnes disease and its significant economic impact on the livestock industry, underscoring the need for advanced diagnostic methods. Technological advancements in diagnostics, such as PCR and serological tests, have significantly improved the accuracy and speed of detection. These improvements are making diagnostic techniques more appealing to veterinarians and livestock owners. Moreover, the emphasis on animal welfare and sustainable farming practices has further driven the adoption of reliable diagnostic methods to identify and manage infected livestock effectively.

Together, these factors are contributing to the positive growth trajectory of the Johnes disease diagnostics market. Johnes disease diagnostics employ various methods to detect MAP, including the Enzyme-Linked Immunosorbent Assay (ELISA), which identifies antibodies, and the Polymerase Chain Reaction (PCR) test, which detects MAP DNA in fecal samples. Early and accurate diagnosis is critical for controlling disease spread and minimizing economic losses. By test type, the PCR segment held the largest market share at 45.3% in 2023. This segment's growth is driven by its high accuracy, sensitivity, and ability to detect MAP at early stages.

Innovations in PCR technology have also made it more accessible and cost-effective for veterinary diagnostics, which has fueled its popularity. The increasing awareness of Johnes disease's impact on livestock productivity and the demand for reliable diagnostic tools have further strengthened the PCR segment's position. In terms of animal type, the cattle segment dominated the market with a value of USD 581.7 million in 2023. Due to the disease's prevalence in dairy herds, there is a high demand for diagnostic solutions to mitigate the disease's effects on milk production, weight, and overall health. This need for early detection supports the growth of diagnostics in this segment.

Regionally, North America led the Johnes disease diagnostics market, valued at USD 271.8 million in 2023, with an anticipated CAGR of 5.1% during the forecast period. The region's advanced veterinary infrastructure, increased awareness among producers, and robust regulatory frameworks for disease control are key growth drivers. Meanwhile, the U.S. market accounted for USD 248.7 million in 2023, with a projected increase to USD 380.9 million by 2032, supported by strong government initiatives and the widespread use of advanced diagnostics like PCR and ELISA.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing livestock population
    • 3.2.1.2 Rising veterinary healthcare expenditure
    • 3.2.1.3 Johne's disease eradication programs and heightened awareness of paratuberculosis
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Complexity and time-consuming nature of tests
    • 3.2.2.2 Asymptomatic nature of disease
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Enzyme-linked immunosorbent assay (ELISA)
• 5.3 Polymerase chain reaction (PCR)
• 5.4 Agar gel immunodiffusion (AGID)

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Cattle
• 6.3 Goat
• 6.4 Sheep
• 6.5 Other animal types

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
  • 7.3.7 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 BioMerieux SA
• 8.2 Idexx Laboratories, Inc.
• 8.3 INDICAL BIOSCIENCE GmbH
• 8.4 Innovative Diagnostics (IDvet)
• 8.5 MV Diagnostics
• 8.6 Pictor diagnostics
• 8.7 Tetracore, Inc.
• 8.8 Thermo Fisher Scientific Inc.
• 8.9 VMRD, Inc.
• 8.10 Zoetis Inc.